- Report
- July 2024
- 70 Pages
Brazil
From €4486EUR$4,750USD£3,815GBP
- Report
- April 2023
- 74 Pages
Global
From €3500EUR$3,970USD£3,081GBP
- Report
- April 2025
- 50 Pages
Global
From €2503EUR$2,650USD£2,129GBP
Nateglinide is a drug used to treat type 2 diabetes, a condition in which the body does not produce enough insulin or does not use insulin properly. It belongs to a class of drugs known as meglitinides, which work by stimulating the pancreas to produce more insulin. Nateglinide is used in combination with diet and exercise to help control blood sugar levels. It is typically prescribed when other treatments, such as metformin, have not been successful.
Nateglinide is part of the larger Endocrine and Metabolic Disorders Drugs market, which includes drugs used to treat a variety of conditions, such as diabetes, thyroid disorders, and obesity. These drugs are used to help regulate hormones and metabolism, and can be taken orally or injected.
Companies in the Nateglinide market include Novartis, Sanofi, Merck, and Eli Lilly. Show Less Read more